Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Stock-Based Compensation

Compensation costs that have been included in our condensed consolidated statements of operations and comprehensive loss for all stock-based compensation arrangements is set forth below:


		Three months ended March 31,
Stock-based compensation		2025				2024
Cost of revenues		$	15			$	45
Sales and marketing			8				14
General and administrative			67				556
Research and development			(4	)			15
Total stock-based compensation		$	86			$	630

Schedule of Restricted Stock Unit Activity

A summary of our restricted stock unit activity for the three months ended March 31, 2025 is set forth below:


		Shares				Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2024			38,420			$	23.01
Granted			-				-
Released			-				-
Forfeited			(3,000	)			14.00
Outstanding as of March 31, 2025			35,420			$	23.77

Schedule of Stock Option Activity

A summary of our stock option activity under the 2018 Equity Incentive Plan (the “2018 Plan) and related information is as follows:


		Number of Shares				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value
Outstanding as of December 31, 2024			2,500			$	56.89
Granted			-				-
Exercised			-				-
Forfeited			(1,500	)		$	38.15
Outstanding as of March 31, 2025			1,000			$	85.00			7.36		$	-
Exercisable as of March 31, 2025			1,000			$	85.00			7.36		$	-

A summary of our option activity under our 2009 Equity Incentive Plan (the “2009 Plan”) and related information is as follows:


		Number of Shares				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value
Outstanding as of December 31, 2024			1,190			$	91.61
Granted			-				-
Exercised			-				-
Forfeited			-			0
Outstanding as of March 31, 2025			1,190			$	91.61			2.25		$	-
Exercisable as of March 31, 2025			1,190			$	91.61			2.25		$	-